NR4A1 and lung carcinoma: Although detailed information about individual endocrine therapy was absent, as most hormone receptor positive BC patients will receive endocrine therapy and the evidence listed above, our study implies some inhibitory effect of endocrine therapy on lung cancer carcinogenesis and progression.